Skip to content

Posts by Hersh Bendre, MD

  • An AI-driven model under development at Mass General Brigham may one day give urologists a sharper tool for predicting prostate cancer risk before radical prostatectomy. In an internal retrospective evaluation, the model far outpaced standard clinical approaches.

Biography

Hersh Bendre, MD is a urologic oncology fellow at Massachusetts General Hospital.

Mass General Bladder, Kidney, Penile, Prostate and Testicular Cancer Program

Physicians in the Mass General Bladder, Kidney, Penile, Prostate and Testicular Cancer Program specialize in using advanced surgical therapies and minimally invasive procedures to treat male and female genitourinary cancers.